Prevalence of the Metabolic Syndrome Among Patients Receiving Clozapine - Lamberti, J. Steven; Olson, David; Crilly, John F.; Olivares, Telva; Williams, Geoffrey C.; Tu, Xin; Tang, Wan; Wiener, Karen; Dvorin, Steven; Dietz, Marci B. (The American journal of psychiatry, 2006)
Keywords: Adolescent; Adult; Age Factors; Ambulatory Care; Antipsychotic Agents - adverse effects; Antipsychotic Agents - therapeutic use; Biological and medical sciences; Blood pressure; Body Mass Index; Cardiovascular disease; Cholesterol; Clinical medicine; Clozapine - adverse effects; Clozapine - therapeutic use; Diabetes; Drug therapy; Drugs; Female; Humans; Logistic Models; Male; Medical sciences; Medical treatment; Metabolic diseases; Metabolic syndrome; Metabolic Syndrome - chemically induced; Metabolic Syndrome - epidemiology; Middle Aged; Miscellaneous; Mortality; Neuropharmacology; Nutrition Surveys; Other metabolic disorders; Pharmacology. Drug treatments; Prevalence; Psycholeptics: tranquillizer, neuroleptic; Psychology. Psychoanalysis. Psychiatry; Psychopharmacology; Psychotic Disorders - drug therapy; Psychotropic drugs; Risk Factors; Schizophrenia; Schizophrenia - drug therapy; Studies; Endocrinopathy; Human; Atypical antipsychotic; Prevalence; Psychotropic; Neuroleptic; Cardiovascular disease; Metabolic diseases; Clozapine; Epidemiology; Chemotherapy; D2 Dopamine receptor; Treatment; X Syndrome; Antagonist; Public health